West Lafayette, Ind.-based CRO BASi appointed Anthony Chilton, Ph.D., chief operating officer, scientific services. In this role, Chilton will oversee scientific services provided to BASi’s clients from its locations in North America and Europe.
Chilton has over 30 years of experience as a scientist and executive in leading life sciences companies in England, Canada and the United States. Most recently, Chilton led early development programs at Atherogenics in Alpharetta, Ga.
“Dr. Chilton is a superb addition to our long-term scientific staff and leadership team,” said BASi president and CEO Richard Shepperd in a company statement. “His extensive industry expertise will be an asset to our partnerships with the biotech and pharmaceutical industry.”
The CRO also hired Jack Polidoro, Ph.D., as business development representative for BASi’s Evansville, Ind., operation. He will focus on large and small pharmaceutical, biotech and medical device clients. Polidoro, a reproductive biologist by training, brings more than 25 years of experience from the preclinical CRO business development arena.